XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning Balance at Dec. 31, 2021 $ 1,609,487 $ 2,993 $ 3,171,536 $ (198,316) $ 5,915 $ (1,372,641) $ 0
Beginning Balance (in shares) at Dec. 31, 2021   299,269,000          
Net income (loss) 154,658     154,658      
Foreign currency translation adjustment 1,793       1,793    
Release of cumulative translation adjustment (7,708)       (7,708)    
Issuance of restricted stock 0 $ 10 (10)        
Issuance of restricted stock (in shares)   980,000          
Vesting of restricted stock units 0 $ 14 (14)        
Vesting of restricted stock units (in shares)   1,437,000          
Exercise of stock options 10,368 $ 6 10,362        
Exercise of stock options (in shares)   640,000          
Stock-based compensation 21,099   21,099        
Payment of cash dividends (43,096)     (43,096)      
Dividend equivalents (640)     (640)      
Purchase of treasury stock (80,438)         (80,438)  
Ending Balance at Dec. 31, 2022 1,665,523 $ 3,023 3,202,973 (87,394) 0 (1,453,079) 0
Ending Balance (in shares) at Dec. 31, 2022   302,326,000          
Net income (loss) 245,952     246,292     (340)
Foreign currency translation adjustment 472       472    
Noncontrolling interest 8,729           8,729
Release of cumulative translation adjustment 0            
Issuance of common stock - Ulterra acquisition 521,406 $ 349 521,057        
Issuance of common stock - Ulterra acquisition (in shares)   34,900,000          
Issuance of common stock - NexTier merger 2,565,895 $ 1,720 2,564,175        
Issuance of common stock - NexTier merger (in shares)   172,092,000          
Issuance of replacement awards related to NexTier merger 72,413   72,413        
Issuance of restricted stock 0 $ 10 (10)        
Issuance of restricted stock (in shares)   1,077,000          
Vesting of restricted stock units 0 $ 64 (64)        
Vesting of restricted stock units (in shares)   6,380,000          
Stock-based compensation 46,750   46,750        
Payment of cash dividends (100,034)     (100,034)      
Dividend equivalents (1,829)     (1,829)      
Purchase of treasury stock (204,596)         (204,596)  
Ending Balance at Dec. 31, 2023 $ 4,820,681 $ 5,166 6,407,294 57,035 472 (1,657,675) 8,389
Ending Balance (in shares) at Dec. 31, 2023 516,775,313 516,775,000          
Net income (loss) $ (966,399)     (968,031)     1,632
Foreign currency translation adjustment (3,056)       (3,056)    
Release of cumulative translation adjustment 0            
Issuance of restricted stock 0 $ 7 (7)        
Issuance of restricted stock (in shares)   719,000          
Vesting of restricted stock units $ 0 $ 33 (33)        
Vesting of restricted stock units (in shares)   3,291,000          
Exercise of stock options (in shares) 0            
Stock-based compensation $ 46,352   46,352        
Payment of cash dividends (126,791)     (126,791)      
Dividend equivalents (1,551)     (1,551)      
Purchase of treasury stock (293,392)         (293,392)  
Ending Balance at Dec. 31, 2024 $ 3,475,844 $ 5,206 $ 6,453,606 $ (1,039,338) $ (2,584) $ (1,951,067) $ 10,021
Ending Balance (in shares) at Dec. 31, 2024 520,784,783 520,785,000